Xianglin Yuan

机构：Tongji Hospital, Huazhong University of Science and Technology

发表论文 54 篇 · 总被引 2775 次 · h-index 16

代表论文

• The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023 (2023 · 癌症：英文版 · 被引 412)
• Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial (2022 · BMC Medicine · 被引 84)
• The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update (2024 · 癌症：英文版 · 被引 67)
• Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma (2022 · Cell Reports Medicine · 被引 53)
• Nintedanib Mitigates Radiation-Induced Pulmonary Fibrosis by Suppressing Epithelial Cell Inflammatory Response and Inhibiting Fibroblast-to-Myofibroblast Transition (2024 · International Journal of Biological Sciences · 被引 30)
• Exploring combination therapy centered on targeted immunotherapy for advanced hepatocellular carcinoma: a beacon of hope (2024 · Oncology and Translational Medicine · 被引 20)